About krishgen

Changing India’s biotech landscape by

developing tools for the life sciences and agri

industry

We Deliver More ™

D & B / SMERA Rated

We are a single owner firm established in 2003, located in thecommercial hub of India – Mumbai or erstwhile Bombay.

KRISHGEN today operates in the broad segments of medicaldiagnostics, drug discovery research, biopharmaceuticals and plant /food sciences.

The compounded average growth in the past three years has been 74%p.a. KRISHGEN gross revenues as of 2011 were USD5,0 million.

A KRISHGEN PRESENTATION © 2011

HOW TO USE THIS GUIDE:About KRISHGEN

Targeting the research and diagnostics markets, our goal is to enable

breakthroughs in biological research, diagnostics, drug discovery and

the treatment of disease. We enjoy a dominant position in the provision

of immunoassay kits, supply of primary human cells and cell

lines, glycobiology and preclinical toxicology tools.

KRISHGEN takes a highly collaborative approach to business

relationships with its customers and partners. We are committed to

providing our customers with world-class solutions, service and support.

Our track record of delivering innovative new products, by distribution

arrangements with leading companies worldwide or the judicious

interface with the academia has given us the broadest range of products

available. The strength lies in our ability to understand technologies and

support the scientists with technical backup and strong logistics.


About KRISHGEN

KRISHGEN meets the needs of its pharmaceutical and clinical

customers by providing a range of Research Use Only kits for

researchers in drug development and pre-clinical studies, and in offering

fully-optimized and validated products for ensuing preclinical and clinical

studies.

KRISHGEN’s recently released cytokine ELISA kits are an innovative

cost effective tool for disease research, drug discovery &

development, and molecular diagnostic test development.

KRISHGEN is funded privately through its owners and private investors.

It is a non-listed, non-traded SME, rated by Dun & Bradstreet / SMERA

(SME Rating Agency of India).

Our DUNS Number is 65-039-6034.


Our History

To support it's plans, Krishgen initially focused on developing marketing

and distribution support for diagnostics.

2004.. First Partner for distribution tied-up with Medipan GmbH / Generic Assays

GmbH in Germany.

2005 .. the research and life sciences products were introduced with its arrangements

with leading US & European companies.

2006 .. the Glycobiology line was introduced in October for distribution.

2007 .. the tools for preclinical toxicology were introduced in August.

2008 .. Promocell GmbH, Germany distribution started in India. Its own products under

the KRISHGEN label were manufactured and introduced in October. Krishgen started

offering immunoassay development services in Nov 2008.

2009 .. KRIBIOLISA bioprocess ELISA kits launched.

2010 .. KRISHILISA GMO ELISA kits and Gold Ring Cytokine ELISAs launched.

2011 .. International distribution efforts started.

KRISHGEN's product and service are now used by respected

academic, biotech, pharmaceutical and government laboratories in India

and worldwide.


KRISHGEN BIOSYSTEMS

– Group Holding Proprietary Company

Revenues* 2011 USD 5,0million

Focuses on diagnostics, drug discovery

research, plant / agri sciences

and food safety

Kodon Sciences

(India)KRISHTECH Solutions

Kodon Sciences (India) – focuses on plant sciences and food safety assays.

Established in 2008.

KRISHTECH Solutions – focuses on biopharmaceutical and vaccine

manufacturing companies. Established in 2009.


Advisory Team

Raman Jain, MSc (Northwestern University, US)

Over 38 years experience in healthcare industry. Previously Managing Director, Nirlac Chemicals andthen Fortex Remedies Pvt Ltd, contract manufacturer of sterile pharmaceuticals. Member : IndianPharmaceutical Association. Founder Member Indian Drug (Pharmaceutical) Manufacturers Association

Kawar Prashant Govindrao

Scientist (PMB), Molecular Biology & Genetic Engineering Lab., Vasantdada Sugar Institute, Pune

Dr I Khatkhatay

Senior Scientist, National Institute For Research in Reproductive Health, Mumbai

Dr Meena Desai

Scientist, National Institute For Research in Reproductive Health, Mumbai

Aditya Jain, MBA (Drexel University, USA)

Vice President, LaReina Collection, Los Angeles, USA.


Investors / Source of Funds

Bank Of India

Owner’s Seed Capital

Private Investors :

Veerchand Manawat Family

Kalpesh Jain HUF


Business Concept

KRISHGEN believes in professionalism. Right from choosing principalswhich we have done with great care to our sales channel partners orour marketing team we have applied one principle – the approach andprofessionalism of the entity to the job at hand.

We believe that a systematic approach and focus to the job will ensurethat all set targets and goals are achieved.

No fancy management jargons but a simple approach of doing the jobgiven sincerely and keeping the customer happy. Our philosophy – WeDeliver More – encompasses all that we believe in.


Our Sales Network

We currently hold distribution rights for sales in South East Asia as well

as in countries including

Singapore, Malaysia, Thailand, Vietnam, Philippines for a number of

our principal companies.

Our focus the past few years has been in India which is our principal

market and the major revenue earner.

We reach the entire Indian region with our own employee based

marketing field team supported by our product executives and

application specialists.

KRISHGEN also now has a network of distributors all across the world

for its own manufactured / branded products. It also supplies on OEM

labeling to leading US and Canadian based companies.


Technical Sales & Marketing Support

Regular Literatures and mailing on specific products and applications.

(we use Constant Contact email marketing tool)

CD presentations on Product Category Focus

Training of Technicians / Users at our application laboratory

Participation in Trade Shows, Conferences, Exhibitions

Conducting Roadshows


Resources Library

We have the largest resources library for marketing our products in

terms of flyers, catalogs, brochures, technical series mails etc. Our in-

house print shop has capacity to print and mail over 10,000 copies per

month which we use in conjunction with our database.

Promotions & Offers

We conduct regular promotions and seasonal offers to boost sales and

highlight products.


Markets and Achievements

KRISHGEN today holds over 80% of the market for biopharmaceuticals with its

glycosylation tools working with world’s leading companies.

With our focus on costs and services, we are a `strategic vendor’ and ‘preferred

partner’ to a number of leading biopharma and vaccine companies.

We were the first movers to market exclusively Invitrogen’s primary human cell

cultures and medias (erstwhile Cascade Biologics)in India from 2004 till 2008

when Invitrogen Corporation, USA set up it’s own subsidiary in India.

We hold over 74% market share for the ADME Tox in India with our nearest

competitor being BD Biosciences and Invitrogen.

We are the market leaders in India for Vitamin D assays for medical diagnostics

and for immunoassay tools for diabetes research and clinical studies.

We have developed and now market exclusively our own manufactured

bioprocess contamination kits for the Indian biopharmaceutical sector as well as

a host of products.


Our Certifications

We are registered with our

Food & Drug Administration

Ministry of Animal Husbandry

Ministry of Health & Family Welfare

Director-General of Foreign Trade

Dun & Bradstreet / SMERA

Our Association Memberships

Member – Indian Merchant Chambers

Member – Indo German Chamber of Commerce

Member – Association of Biotechnology Led Enterprises

Member - National Seed Association of India


Scientific Presentations

Posters Presented -

2009 Immunocon, Bangalore Development and validation of a generic E.coli HCP ELISA for determination of host cell

proteins for biopharmaceuticals expressed in E.coli

2010 Bangalore India Bio, BangaloreDevelopment and validation of cost effective assay for Development and validation of

ELISA for qualitative assessment of Cry 2Ab protein in Bt Cotton

Development and analytical validation of a generic ELISA kit for measurement of Host Cell

Proteins in Chinese Hamster Ovary cells.

Use of indigenous ELISA for estimation of cytokines and estradiol levels in women


Energy

Enterprise

Enthusiasm

Our 3 E’s of Business

which has enabled us to

make KRISHGEN, India’s

leading biotech company

with products presence in

major markets across the

world.


Partner us in your efforts to market and

sell your products leveraging our

capabilities in one of Asia’s largest

market.

Talk to us to work together to increase

the reach of our products.

We would be happy to connect –

email : [email protected]

[email protected]

Tel: +1-213-2913096 (US)

+91-22-66372990 (India)

Fax: +1-213-4022025 (US)

+91-22-66372991 (India)


About krishgen

Documents

Transcript of About krishgen